Founded in 2007, PaxVax is a fully integrated specialty vaccine company with a mission to protect people from infectious diseases. The company seeks both financial returns through two specialty business strategies in travelers and biodefense vaccines as well as social returns by providing access to its vaccines globally and by developing vaccines addressing some of the world's most lethal infectious diseases.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/30/14 | $12,000,000 | Series B |
Blue Haven Initiative Ignition Capital Ignition Ventures | undisclosed |
